GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Balance Sheet Cash And Cash Equivalents

SillaJen (XKRX:215600) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2016. Start your Free Trial

What is SillaJen Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


SillaJen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Balance Sheet Cash And Cash Equivalents
Traded in Other Exchanges
N/A
Address
6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274
SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.